Every report the desk has filed, searchable by full text, topic, format, symbol and date range.
Snowflake director Frank Slootman sold $100.3 million in stock while BlackSky's CEO, CFO and general counsel all filed separate sales.
Snowflake director Frank Slootman sold $100.3 million in company shares, coinciding with a cluster of insider sales at satellite-imagery firm BlackSky, including its CEO's $457,600 disposal.
BofA, Rosenblatt and Morgan Stanley all raised targets this week, citing AI-driven growth and, for Robinhood, upside independent of crypto trading.
Morgan Stanley raised its Robinhood price target from $124 to $150, implying a 43% gain from current levels, while BofA lifted Microsoft's target to $600 and Rosenblatt raised Snowflake's to $345.
A Snowflake director sold $97.4 million in shares and CrowdStrike's CEO sold more than $4.1 million, adding to a run of large insider disposals across software names.
Snowflake director Frank Slootman sold $97.4 million in stock and CrowdStrike CEO George Kurtz sold over $4.1 million, the latest in a string of insider sales at richly valued software companies.
Snowflake, Rhythm Pharmaceuticals and Krystal Biotech executives lead more than $40 million in disclosed disposals, with Dutch Bros the rare insider buy
A dense cluster of Form 4 filings shows heavy insider distribution across software and biotechnology, led by a $16.8 million Snowflake director sale and roughly $15.5 million of combined Rhythm Pharmaceuticals executive sales, while insider buying was limited to a single Dutch Bros board purchase.
Snowflake, Airbnb and LandBridge insiders offloaded hundreds of millions in stock, while a cluster of small-cap secondary offerings signals issuers rushing to capitalise on receptive equity windows.
A concentrated cluster of Form 4 disclosures showed Snowflake executives selling over $26m combined, Airbnb's CEO divesting $35m, and a LandBridge director unloading $93.8m. Simultaneously, Londian Wason priced a $94.3m IPO and Silence Therapeutics raised $175m, pointing to a supply-side response to elevated valuations and open capital markets.